Trial Profile
Clinical trial randomized and controlled to compare the analgesic efficacy of the association zoledronic acid and 153Sm-lexidronam vs zoledronic acid in patients with skeletal metastases from hormono-refractory prostatic neoplasia and moderate-severe bone pain associated [Studio clinico randomizzato e controllato per comparare l'™efficacia analgesica dell'™associazione acido zoledronico e 153Sm-lexidronam verso acido zoledronico in pazienti affetti da metastasi ossee da neoplasia prostatica ormono-refrattaria con dolore associato a cancro di intensita' moderata-severa]
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Oct 2013
Price :
$35
*
At a glance
- Drugs Samarium 153 lexidronam (Primary) ; Zoledronic acid
- Indications Cancer pain
- Focus Therapeutic Use
- 14 Oct 2013 New trial record